Regenerative Medicines Market by Technologies (Biomaterials, Stem Cell Therapy, Tissue Engineering), and Applications (Allogeneic Bones, Autogenic Bones, Bone Graft Substitutes, Osteoarticular Diseases) and Forecast 2017-2021

Regenerative Medicines Market by Technologies (Biomaterials, Stem Cell Therapy, Tissue Engineering), and Applications (Allogeneic Bones, Autogenic Bones, Bone Graft Substitutes, Osteoarticular Diseases) and Forecast 2017-2021

Regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. It is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. Regenerative medicines comprised of stem cell therapy, tissue engineering and biomaterials. Regenerative medicine has wide range of applications in cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. Increasing bone and joint reconstructive surgeries, high prevalence of various osteoarticular diseases and favorable reimbursement policies are expected to drive the global regenerative medicine market during the forecast period.

The global regenerative medicines market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).

The global regenerative medicines market segmentation is based on technologies (biomaterials, stem cell therapy, tissue engineering), and its applications (allogeneic bones, autogenic bones, bone graft substitutes, osteoarticular diseases).

The global regenerative medicines market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global regenerative medicines market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global regenerative medicines market and included in this report are Anika Therapeutics, Inc., Arthrex, Inc., Baxter International, Inc., CONMED Corporation, DePuy Synthes, Inc., Medtronic, Inc., Smith & Nephew PLC, Stryker Corporation and Zimmer Holdings, Inc.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Product Type (cells, media, serum, vaccine, protein, instrument, etc.)
    • Source Type
    • Reagents and Consumables Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  8. Recommendations
  9. References

Regenerative Medicines Market

1. Technology
1.1. Biomaterials
1.2. Stem Cell Therapy
1.3. Tissue Engineering

2. Application
2.1. Allogeneic Bones
2.2. Autogenic Bones
2.3. Bone Graft Substitutes
2.4. Osteoarticular Diseases
2.5. Others

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. Anika Therapeutics, Inc.
4.2. Arthrex, Inc.
4.3. Baxter International, Inc.
4.4. CONMED Corporation
4.5. DePuy Synthes, Inc.
4.6. Medtronic, Inc.
4.7. Smith & Nephew plc
4.8. Stryker Corporation
4.9. Zimmer Holdings, Inc.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*